Quick Answer
HERON THERAPEUTICS, INC. /DE/ reported Stockholders Equity of $14.33 million for the year ending 2025.
- HERON THERAPEUTICS, INC. /DE/ showed an increase of +142.6% in Stockholders Equity from 2024 to 2025.
- This data is from HERON THERAPEUTICS, INC. /DE/'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2014: $55.41 million | Q2 2014: $97.85 million | Q3 2014: $81.01 million | Q1 2015: $48.00 million | Q2 2015: $159.87 million | Q3 2015: $141.70 million | Q1 2016: $92.68 million | Q2 2016: $57.84 million | Q3 2016: $17.88 million | Q1 2017: $102.16 million | Q2 2017: $69.08 million | Q3 2017: $40.05 million | Q1 2018: $92.21 million | Q2 2018: $431.89 million | Q3 2018: $406.81 million | Q1 2019: $331.81 million | Q2 2019: $305.36 million | Q3 2019: $285.44 million | Q1 2020: $365.47 million | Q2 2020: $324.06 million | Q3 2020: $277.15 million | Q1 2021: $196.23 million | Q2 2021: $160.11 million | Q3 2021: $118.84 million | Q1 2022: $23.96 million | Q2 2022: -$21.74 million | Q3 2022: $22.45 million | Q1 2023: -$11.43 million | Q2 2023: -$39.28 million | Q3 2023: -$27.79 million | Q1 2024: -$33.77 million | Q2 2024: -$37.94 million | Q3 2024: -$40.01 million | Q1 2025: -$28.45 million | Q2 2025: -$27.26 million | Q3 2025: $14.89 million.
- Over the full 15 years of available data (2011 to 2025), HERON THERAPEUTICS, INC. /DE/'s Stockholders Equity has declined by 9.0%.
- Historical annual values: Fiscal year 2025: $14.33 million | Fiscal year 2024: -$33.65 million | Fiscal year 2023: -$33.97 million | Fiscal year 2022: $13.57 million | Fiscal year 2021: $77.57 million | Fiscal year 2020: $236.49 million | Fiscal year 2019: $403.84 million | Fiscal year 2018: $370.16 million | Fiscal year 2017: $131.14 million | Fiscal year 2016: -$21.25 million | Fiscal year 2015: $118.11 million | Fiscal year 2014: $63.06 million | Fiscal year 2013: $68.95 million | Fiscal year 2012: $51.82 million | Fiscal year 2011: $15.75 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: